Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
The current price of COR is $296.51 USD — it has increased by +2.8% in the past 24 hours. Watch Cencora stock price performance more closely on the chart.
What is Cencora stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cencora stocks are traded under the ticker COR.
Is Cencora stock price growing?▼
COR stock has risen by +3.63% compared to the previous week, the month change is a +7.81% rise, over the last year Cencora has showed a +0.09% increase.
What is Cencora market cap?▼
Today Cencora has the market capitalization of 57.69B
When is the next Cencora earnings date?▼
Cencora is going to release the next earnings report on August 05, 2026.
What were Cencora earnings last quarter?▼
COR earnings for the last quarter are 4.75 USD per share, whereas the estimation was 4.82 USD resulting in a -1.42% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cencora revenue for the last year?▼
Cencora revenue for the last year amounts to 642.67B USD.
What is Cencora net income for the last year?▼
COR net income for the last year is 3.11B USD.
Does Cencora pay dividends?▼
Yes, COR dividends are paid quarterly. The last dividend per share was 0.6 USD. As of today, Dividend Yield (FWD)% is 0.81%.
How many employees does Cencora have?▼
As of July 05, 2026, the company has 47,000 employees.
In which sector is Cencora located?▼
Cencora operates in the Health & Wellness sector.
When did Cencora complete a stock split?▼
The last stock split for Cencora was on June 16, 2009 with a ratio of 2:1.
Where is Cencora headquartered?▼
Cencora is headquartered in Conshohocken, United States.